Cannabis Law Report

JUNE 20, 2019

Chronic pain. Medical cannabis is known to possess pain-relieving properties. Thus, many people often use it to relieve themselves of chronic pain, muscle pain, and pain in the joints. Chronic pain is the primary cause of disability in many people worldwide.

History 67

History Medicine Chronic Pain Conditions 67

Cannabis Law Report

OCTOBER 20, 2019

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. xi] “Pharmaceutical Research and Manufacturers of America (PhRMA) spent $19.7 as a Schedule II substance.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: The Guardian ). Source: SIPSE.COM ). t be denied.

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Key Topics Covered: Chapter 1 Methodology and Scope. Chronic Pain. GW Pharmaceuticals, plc.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Weedistry

MARCH 9, 2019

Both CBD and THC (another cannabinoid that is found in large quantities) have incredible effects on the body that rival even the most well-recognized and powerful pharmaceuticals on the market. This makes CBD an effective treatment option for all sorts of pain, including chronic pain and conditions like arthritis.

CBD 40

CBD Epilepsy Treatment Chronic Pain 40

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. We continue to enhance our product pipeline, and because of our unique delivery technologies we have expanded our targeted indications beyond pain to include Central Nervous System (CNS) disorders and anti-viral indications. “Our

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

JANUARY 4, 2022

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. Virpax”), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Pharmaceutical 52

Pharmaceutical Research and Development Chronic Pain Events 52

Cannabis Law Report

SEPTEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. About Virpax Pharmaceuticals.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 28, 2021

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Green Relief

FEBRUARY 20, 2018

I was first introduced to the topic of Epigenetics in 2008 at a business conference in Florida, and as a medical professional I was immediately intrigued. 10/8/2017. 0 COMMENTS. By Janna Champagne, BSN, RN. This supports what we’ve known for a long time: that given what it needs, the body can balance and heal itself.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Cannabis Law Report

JANUARY 18, 2022

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. BERWYN, Pa.–(BUSINESS

Safety 52

Safety Chronic Pain Research and Development Pharmaceutical 52

Cannabis Law Report

DECEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., About Virpax Pharmaceuticals.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

NOVEMBER 10, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

OCTOBER 1, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, today announced that Chairman and CEO Anthony P. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Key Topics Covered: Chapter 1 Methodology and Scope. Chronic Pain. GW Pharmaceuticals, PLC.

Recreational 95

Recreational Hemp THC Legalization 95

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

OCTOBER 6, 2021

With the additional funding recently secured by Virpax and the strengthening of our balance sheet, we are continuing to advance our product candidates and to move them through preclinical studies and into human clinical trials,” said Anthony Mack, Chairman and Chief Executive Officer of Virpax Pharmaceuticals. About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

DECEMBER 8, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

SEPTEMBER 12, 2021

There are clinical studies that show pure cannabis is more efficient than cannabis-based pharmaceuticals, and that it may produce less adverse effects. Products infused with isolated THC mostly include oils, edibles and topicals. The main consumption methods are oral, inhalation, topical (dermal), and transdermal.

THC 98

THC Research and Development Cannabinoids CBD 98

Miss Marijuana

MAY 17, 2020

In addition to its anti-inflammatory properties, studies indicate that medical marijuana can be used as an effective option for natural pain relief. A 2010 survey of patients suffering from chronic pain resulted in a 64% decrease in symptoms when treated with medical marijuana. Improved Mental Health. Natural Muscle Relaxant .

Marijuana 52

Marijuana Sleep Treatment Chronic Pain 52

Miss Marijuana

MAY 17, 2020

In addition to its anti-inflammatory properties, studies indicate that medical marijuana can be used as an effective option for natural pain relief. A 2010 survey of patients suffering from chronic pain resulted in a 64% decrease in symptoms when treated with medical marijuana. Improved Mental Health. Natural Muscle Relaxant .

Marijuana 52

Marijuana Sleep Treatment Chronic Pain 52

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. the form the finished product can take (edibles, topicals, etc.). how the segments are defined (e.g.,

Law 40

Law Seed-To-Sale Hemp Recreational 40